Previous 10 | Next 10 |
Guided Therapeutics (GTHP) announces that it has raised a total of $1.1M so far, under the terms of a Series F Preferred Stock Offering.The private placement offering targeted at least $1M and the financing can continue to raise additional funds until closing this tranche, forecast for l...
Funds will be used to Help Complete Enrollment in US FDA Study Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has thus far raised a total of US $1.1 million...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had made the final payment of $750,000 to GPB Capital Holdings, LLC under a cash and equity exchange agreement signed on January 16, 2020. Under the agreement, once the agree...
Guided Therapeutics ([[GTHP]] +5.2%) announces that it had received a new purchase order of ~$530K from its Chinese co-manufacturing partner and distributor for China, Shandong Yaohua Medical Instrument.The new purchase order stipulates a 10% down payment in January 2021 with the balance...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva® Advanced Cervical Scan, based on its patented biophotonic technology, announced today that it had received a new purchase order in the amount of $530,695 from its Chinese co-manufacturing partner and distributor for ...
Established with Distribution Partner Newmars Technologies, Kft to Facilitate Sales and Marketing Starting in 2021 Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced the opening of a...
Guided Therapeutics, Inc. (OTCQB: GTHP) has developed a rapid and painless testing platform for the early detection of disease based on its patented biophotonic technology that utilizes light to detect disease at the cellular level. The company’s first product, LuViva™, is...
Following the successful meeting with FDA on October 14, Guided Therapeutics ([[GTHP]]) to commence clinical study in support of its premarketing application for the LuViva® Advanced Cervical Scan.The Company filed the minutes of the meeting with FDA which the agency will revi...
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced today the successful outcome of its October 14, 2020 meeting with FDA. The purpose of the meeting was to finalize the protoco...
Guided Therapeutics ( OTCQB:GTHP ) ships four LuViva Advanced Cervical Scan systems and associated disposables to its Chinese co-manufacturing partner and distributor for China, Shandong Yaohua Medical Instrument Corporation. More news on: Guided Therapeutics, Inc., Healthcare s...
News, Short Squeeze, Breakout and More Instantly...
Guided Therapeutics Inc Company Name:
GTHP Stock Symbol:
OTCMKTS Market:
Guided Therapeutics Inc Website:
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that leading physicians from four prestigious medical centers have completed their review and signed off on the study results for submission to the Chinese National Medical Products Administra...
Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023 CISO Global, Inc (CISO) is expected to report for Q4 2023 TCTM Kids IT Education Inc. (TCTM) is expected to report for quarter end 2023-12-31 Generation Income Properties Inc. (GIPR) is expected to report for quart...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...